Do you want to join one of the fastest-growing molecular diagnostics companies to help transform prenatal and oncology diagnostics that can affect millions of patient lives?
BillionToOne, ranked at the top 5% of Y Combinator companies with $250M+ in funding from prominent VC firms, has developed a DNA molecular counter that increases cfDNA diagnostic resolution by over 1,000 fold. BillionToOne's first product, UNITY™ is the first and only non-invasive prenatal test that can directly screen an unborn baby and assess the risk for common and severe recessive gene disorders and chromosomal abnormalities, as well as fetal sex and fetal antigens, from a single tube of blood from the pregnant mother without paternal testing.
In 2023, BillionToOne launched two liquid biopsy products that will markedly improve oncology treatment and care. With Northstar Select™, clinicians will be able to select cancer therapies that will be most effective to each patient based on their individual genetic makeup. Northstar Response™ will enable clinicians to monitor a patient's early response to these cancer therapies, by measuring minute changes in their ctDNA, which can reduce ineffective treatments and unwanted toxicity, lower costs, and substantially improve clinical outcomes.
The Senior Account Executive, Utah is an outstanding sales executive with experience in medical or biological science product sales, who will bring the first and only single-gene NIPT supported carrier and aneuploidy screen to OBGYN clinics & MFMs practices. You will deliver clinical information to both external clients throughout the Utah territory and internal teams. You will have significant influence over how the test is communicated to physicians and patients, and how it should evolve to better serve market needs. This is a remote position and reports to the Regional Sales Manager-Southwest.
Responsibilities:
Requirements:
Nice-to-Haves:
Benefits And Perks:
At BillionToOne, we are proud to offer a combination of a (1) base pay (2) generous equity options offering, on top of (3) industry leading company benefits (free healthcare options, 401k match, very generous fully paid parental leave etc.).
This position offers a starting compensation package including a base of $115,000 + annual commissions of $50,000 if at plan, with opportunity for promotion. Commissions are uncapped and earning potential can be significant.
BillionToOne’s mission is to revolutionize genetic testing through the development of innovative quantitative diagnostics. BillionToOne's DNA Molecular Counting platform integrates next-generation sequencing technologies with machine learning, w...
28 jobsSubscribe to Rise newsletter